Pharmacies in Saudi Arabia do not sell any of the 40 over-the-counter infant's and children's liquid medications which are being recalled in the United States and 11 other countries for failing to meet quality standards. McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., in consultation with the US Food and Drug Administration (FDA) voluntarily issued the recall for children's versions of Tylenol, Tylenol Plus, Motrin, Zyrtec and Benadryl. The medicines were made and distributed in the United States, and exported to Kuwait, Dubai, Canada, the Dominican Republic, Fiji, Guam, Guatemala, Jamaica, Puerto Rico, Panama, and Trinidad and Tobago. Some pharmacies in Jeddah sell Zyrtec flavorless oral suspension, which is not on the recall list. Children's Zyrtec liquids in bottles on the recall list are 4 oz bubblegum syrup, 4 oz grape syrup, 0.5 oz grape, 0.5 oz bubblegum and 2x4 oz bubblegum. The company is recalling the products because some did not meet required quality standards, the company said in a statement Friday. Some of the products recalled may have a higher concentration of active ingredient than is specified on the bottle. Others may contain particles, while still others may contain inactive ingredients that do not meet internal testing requirements, the statement posted on the company's website said. The company is advising consumers to stop giving the products to their children as a precautionary measure. The recall was not undertaken because of any adverse effects, the company said. “While the potential for serious medical events is remote, the company advises consumers who have purchased these recalled products to discontinue use,” the statement said.
